Clinical Study on the Disease-Modifying Effects of Rasagiline on Parkinson's Disease Using Machine Learning

Clinical Study on the Disease-Modifying Effects of Rasagiline on Parkinson's Disease Using Machine Learning - Clinical Study on the Disease-Modifying Effects of Rasagiline on Parkinson's Disease Using Machine Learning

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000053427

Enrollment

325

Registered

2024-01-24

Start date

2019-11-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

Patients with Parkinson&#39

s disease to be additionally treated with rasagiline 1 mg/day. Patients with Parkinson&#39

s disease who do not take rasagiline. Patients with Parkinson&#39

s disease who were treated with rasagiline alone 1 mg/day Healthy subjects

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with sporadic Parkinson's disease attending the Department of Neurology at Juntendo University Hospital. Patients who have received an explanation of this study, understand its contents, and give their consent.

Exclusion criteria

Exclusion criteria: (1) Patients with severely impaired renal function (2) Patients who are pregnant or may be pregnant (3) Patients who are breast-feeding (4) Patients suffering from collagen disease, vasculitis disease, malignant tumor, or severe diabetes mellitus (5) Other patients who are deemed inappropriate as subjects by the principal investigator.

Design outcomes

Primary

Measure	Time frame
Clinical symptoms at baseline, 24, 48, 72, and 96 weeks (UPDRS).	—

Secondary

Measure	Time frame
Blood test, brain MRI scan	—

Countries

Japan

Contacts

Public ContactShinji Saiki

Juntendo University Department of Neurology

ssaiki@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026

Clinical Study on the Disease-Modifying Effects of Rasagiline on Parkinson&#39;s Disease Using Machine Learning